Biosynthesis of Silver Nanoparticles Using the Biofilm Supernatant of Pseudomonas aeruginosa PA75 and Evaluation of Their Antibacterial, Antibiofilm, and Antitumor Activities

References

• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Liu X, Wu Y, Zhu Y, et al. Emergence of colistin-resistant hypervirulent Klebsiella pneumoniae (CoR-HvKp) in China. Emerg Microbes Infect. 2022;11(1):648–661. doi:10.1080/22221751.2022.2036078
   PubMed Web of Science ®Google Scholar
• Collaborators AR, Ikuta KS, Sharara F. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–655. doi:10.1016/S0140-6736(21)02724-0
   PubMed Web of Science ®Google Scholar
• Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–327. doi:10.1016/S1473-3099(17)30753-3
   PubMed Web of Science ®Google Scholar
• Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Infectious Diseases Society of America 2022 guidance on the treatment of Extended-Spectrum β-Lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa). Clin Infect Dis. 2022;75(2):187–212. doi:10.1093/cid/ciac268
   PubMed Web of Science ®Google Scholar
• Zhang S, Abbas M, Rehman MU, et al. Updates on the global dissemination of colistin-resistant Escherichia coli: an emerging threat to public health. Sci Total Environ. 2021;799:149280. doi:10.1016/j.scitotenv.2021.149280
   PubMed Web of Science ®Google Scholar
• Huang PH, Chen WY, Chou SH, Wang FD, Lin YT. Risk factors for the development of colistin resistance during colistin treatment of carbapenem-resistant Klebsiella pneumoniae infections. Microbiol Spectr. 2022;10(3):e0038122. doi:10.1128/spectrum.00381-22
   PubMed Web of Science ®Google Scholar
• Noralian Z, Gashti MP, Moghaddam MR, Tayyeb H, Erfanian I. Ultrasonically developed silver/iota-carrageenan/cotton bionanocomposite as an efficient material for biomedical applications. Int J Biol Macromol. 2021;180:439–457. doi:10.1016/j.ijbiomac.2021.02.204
   PubMed Web of Science ®Google Scholar
• Mo F, Zhou Q, He Y. Nano-Ag: environmental applications and perspectives. Sci Total Environ. 2022;829:154644. doi:10.1016/j.scitotenv.2022.154644
   PubMed Web of Science ®Google Scholar
• Kulkarni RR, Shaiwale NS, Deobagkar DN, Deobagkar DD. Synthesis and extracellular accumulation of silver nanoparticles by employing radiation-resistant Deinococcus radiodurans, their characterization, and determination of bioactivity. Int J Nanomedicine. 2015;10:963–974. doi:10.2147/IJN.S72888
   PubMed Web of Science ®Google Scholar
• Elgorban AM, El-Samawaty AE-RM, Yassin MA, et al. Antifungal silver nanoparticles: synthesis, characterization and biological evaluation. Biotechnol Biotechnol Equip. 2016;30(1):56–62. doi:10.1080/13102818.2015.1106339
   Web of Science ®Google Scholar
• Khan M, Shaik MR, Adil SF, et al. Plant extracts as green reductants for the synthesis of silver nanoparticles: lessons from chemical synthesis. Dalton Trans. 2018;47(35):11988–12010. doi:10.1039/C8DT01152D
   PubMed Web of Science ®Google Scholar
• Mondal AH, Yadav D, Mitra S, Mukhopadhyay K. Biosynthesis of silver nanoparticles using culture supernatant of shewanella sp. ARY1 and their antibacterial activity. Int J Nanomedicine. 2020;15:8295–8310. doi:10.2147/IJN.S274535
   PubMed Web of Science ®Google Scholar
• Adil SF, Assal ME, Khan M, Al-Warthan A, Siddiqui MR, Liz-Marzán LM. Biogenic synthesis of metallic nanoparticles and prospects toward green chemistry. Dalton Trans. 2015;44(21):9709–9717. doi:10.1039/C4DT03222E
   PubMed Web of Science ®Google Scholar
• Marslin G, Siram K, Maqbool Q, et al. Secondary metabolites in the green synthesis of metallic nanoparticles. Materials. 2018;11(6):940–964. doi:10.3390/ma11060940
   PubMed Web of Science ®Google Scholar
• Flemming HC, Wingender J. The biofilm matrix. Nat Rev Microbiol. 2010;8(9):623–633. doi:10.1038/nrmicro2415
   PubMed Web of Science ®Google Scholar
• Davies DG, Chakrabarty AM, Geesey GG. Exopolysaccharide production in biofilms: substratum activation of alginate gene expression by Pseudomonas aeruginosa. Appl Environ Microbiol. 1993;59(4):1181–1186. doi:10.1128/aem.59.4.1181-1186.1993
   PubMed Web of Science ®Google Scholar
• Whitchurch CB, Tolker-Nielsen T, Ragas PC, Mattick JS. Extracellular DNA required for bacterial biofilm formation. Science. 2002;295(5559):1487. doi:10.1126/science.295.5559.1487
   PubMed Web of Science ®Google Scholar
• O’Neill E, Pozzi C, Houston P, et al. A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB. J Bacteriol. 2008;190(11):3835–3850. doi:10.1128/JB.00167-08
   PubMed Web of Science ®Google Scholar
• Thöming JG, Häussler S. Pseudomonas aeruginosa is more tolerant under biofilm than under planktonic growth conditions: a multi-isolate survey. Front Cell Infect Microbiol. 2022;12:851784. doi:10.3389/fcimb.2022.851784
   PubMed Web of Science ®Google Scholar
• Waite RD, Papakonstantinopoulou A, Littler E, Curtis MA. Transcriptome analysis of Pseudomonas aeruginosa growth: comparison of gene expression in planktonic cultures and developing and mature biofilms. J Bacteriol. 2005;187(18):6571–6576. doi:10.1128/JB.187.18.6571-6576.2005
   PubMed Web of Science ®Google Scholar
• Gahlawat G, Shikha S, Chaddha BS, Chaudhuri SR, Mayilraj S, Choudhury AR. Microbial glycolipoprotein-capped silver nanoparticles as emerging antibacterial agents against cholera. Microb Cell Fact. 2016;15:25–38. doi:10.1186/s12934-016-0422-x
   PubMed Web of Science ®Google Scholar
• Khazaei Z, Ghorat F, Jarrahi AM, Adineh HA, Sohrabivafa M, Goodarzi E. Global incidence and mortality of skin cancer by histological subtype and its relationship with the human development index (HDI); an ecology study in 2018. WCRJ. 2019;6:e1265.
   Google Scholar
• Kuang X, Wang Z, Luo Z, et al. Ag nanoparticles enhance immune checkpoint blockade efficacy by promoting of immune surveillance in melanoma. J Colloid Interface Sci. 2022;616:189–200. doi:10.1016/j.jcis.2022.02.050
   PubMed Web of Science ®Google Scholar
• Nayak D, Kumari M, Rajachandar S, Ashe S, Thathapudi NC, Nayak B. Biofilm impeding AgNPs target skin carcinoma by inducing mitochondrial membrane depolarization mediated through ROS production. ACS Appl Mater Interfaces. 2016;8(42):28538–28553. doi:10.1021/acsami.6b11391
   PubMed Web of Science ®Google Scholar
• Gholami N, Cohan RA, Razavi A, Bigdeli R, Dashbolaghi A, Asgary V. Cytotoxic and apoptotic properties of a novel nano-toxin formulation based on biologically synthesized silver nanoparticle loaded with recombinant truncated pseudomonas exotoxin A. J Cell Physiol. 2020;235(4):3711–3720. doi:10.1002/jcp.29265
   PubMed Web of Science ®Google Scholar
• Pasha A, Kumbhakar DV, Sana SS, et al. Role of biosynthesized Ag-NPs using aspergillus niger (MK503444.1) in antimicrobial, anti-cancer and anti-angiogenic activities. Front Pharmacol. 2021;12:812474. doi:10.3389/fphar.2021.812474
   PubMed Web of Science ®Google Scholar
• Nayak D, Thathapudi NC, Ashe S, Nayak B. Bioengineered ethosomes encapsulating AgNPs and Tasar silk sericin proteins for non melanoma skin carcinoma (NMSC) as an alternative therapeutics. Int J Pharm. 2021;596:120265. doi:10.1016/j.ijpharm.2021.120265
   PubMedGoogle Scholar
• Jagtap RR, Garud A, Puranik SS, et al. Biofabrication of silver nanoparticles (AgNPs) using embelin for effective therapeutic management of lung cancer. Front Nutr. 2022;9:960674. doi:10.3389/fnut.2022.960674
   PubMed Web of Science ®Google Scholar
• Gao J, Wang Y, Wang CW, Lu BH. First report of bacterial root rot of ginseng caused by Pseudomonas aeruginosa in China. Plant Dis. 2014;98(11):1577. doi:10.1094/PDIS-03-14-0276-PDN
   PubMed Web of Science ®Google Scholar
• Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987;4(4):406–425. doi:10.1093/oxfordjournals.molbev.a040454
   PubMed Web of Science ®Google Scholar
• Cavassin ED, de Figueiredo LF, Otoch JP, et al. Comparison of methods to detect the in vitro activity of silver nanoparticles (AgNP) against multidrug resistant bacteria. J Nanobiotechnology. 2015;13:64–79. doi:10.1186/s12951-015-0120-6
   PubMed Web of Science ®Google Scholar
• Bendaoud M, Vinogradov E, Balashova NV, Kadouri DE, Kachlany SC, Kaplan JB. Broad-spectrum biofilm inhibition by Kingella kingae exopolysaccharide. J Bacteriol. 2011;193(15):3879–3886. doi:10.1128/JB.00311-11
   PubMed Web of Science ®Google Scholar
• Karwacki MT, Kadouri DE, Bendaoud M, et al. Antibiofilm activity of Actinobacillus pleuropneumoniae serotype 5 capsular polysaccharide. PLoS One. 2013;8(5):e63844. doi:10.1371/journal.pone.0063844
   PubMed Web of Science ®Google Scholar
• Singh P, Pandit S, Garnæs J, et al. Green synthesis of gold and silver nanoparticles from Cannabis sativa (industrial hemp) and their capacity for biofilm inhibition. Int J Nanomedicine. 2018;13:3571–3591. doi:10.2147/IJN.S157958
   PubMed Web of Science ®Google Scholar
• Konaté K, Mavoungou JF, Lepengué AN, et al. Antibacterial activity against β- lactamase producing Methicillin and Ampicillin-resistants Staphylococcus aureus: Fractional Inhibitory Concentration Index (FICI) determination. Ann Clin Microbiol Antimicrob. 2012;11:18–29. doi:10.1186/1476-0711-11-18
   PubMed Web of Science ®Google Scholar
• Allend SO, Garcia MO, da Cunha KF, et al. Biogenic silver nanoparticle (Bio-AgNP) has an antibacterial effect against carbapenem-resistant Acinetobacter baumannii with synergism and additivity when combined with polymyxin B. J Appl Microbiol. 2022;132(2):1036–1047. doi:10.1111/jam.15297
   PubMed Web of Science ®Google Scholar
• Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 2003;52(1):1. doi:10.1093/jac/dkg301
   PubMed Web of Science ®Google Scholar
• Wesseling CMJ, Martin NI. Synergy by perturbing the gram-negative outer membrane: opening the door for gram-positive specific antibiotics. ACS Infect Dis. 2022;8(9):1731–1757. doi:10.1021/acsinfecdis.2c00193
   PubMedGoogle Scholar
• Ahmed T, Shahid M, Noman M, et al. Bioprospecting a native silver-resistant Bacillus safensis strain for green synthesis and subsequent antibacterial and anticancer activities of silver nanoparticles. J Adv Res. 2020;24:475–483. doi:10.1016/j.jare.2020.05.011
   PubMed Web of Science ®Google Scholar
• Almalki MA, Khalifa AYZ. Silver nanoparticles synthesis from Bacillus sp KFU36 and its anticancer effect in breast cancer MCF-7 cells via induction of apoptotic mechanism. J Photochem Photobiol B. 2020;204:111786. doi:10.1016/j.jphotobiol.2020.111786
   PubMed Web of Science ®Google Scholar
• Singh P, Kim YJ, Singh H, et al. Biosynthesis, characterization, and antimicrobial applications of silver nanoparticles. Int J Nanomedicine. 2015;10:2567–2577. doi:10.2147/IJN.S72313
   PubMed Web of Science ®Google Scholar
• Iqtedar M, Aslam M, Akhyar M, Shehzaad A, Abdullah R, Kaleem A. Extracellular biosynthesis, characterization, optimization of silver nanoparticles (AgNPs) using Bacillus mojavensis BTCB15 and its antimicrobial activity against multidrug resistant pathogens. Prep Biochem Biotechnol. 2019;49(2):136–142. doi:10.1080/10826068.2018.1550654
   PubMed Web of Science ®Google Scholar
• Khan T, Yasmin A, Townley HE. An evaluation of the activity of biologically synthesized silver nanoparticles against bacteria, fungi and mammalian cell lines. Colloids Surf B Biointerfaces. 2020;194:111156. doi:10.1016/j.colsurfb.2020.111156
   PubMed Web of Science ®Google Scholar
• Riaz Rajoka MS, Mehwish HM, Zhang H, et al. Antibacterial and antioxidant activity of exopolysaccharide mediated silver nanoparticle synthesized by Lactobacillus brevis isolated from Chinese koumiss. Colloids Surf B Biointerfaces. 2020;186:110734. doi:10.1016/j.colsurfb.2019.110734
   PubMed Web of Science ®Google Scholar
• Gurunathan S, Kalishwaralal K, Vaidyanathan R, et al. Biosynthesis, purification and characterization of silver nanoparticles using Escherichia coli. Colloids Surf B Biointerfaces. 2009;74(1):328–335. doi:10.1016/j.colsurfb.2009.07.048
   PubMed Web of Science ®Google Scholar
• Singh P, Pandit S, Jers C, Joshi AS, Garnæs J, Mijakovic I. Silver nanoparticles produced from Cedecea sp. exhibit antibiofilm activity and remarkable stability. Sci Rep. 2021;11(1):12619. doi:10.1038/s41598-021-92006-4
   PubMed Web of Science ®Google Scholar
• Zamanpour N, Mohammad Esmaeily A, Mashreghi M, Shahnavaz B, Reza Sharifmoghadam M, Kompany A. Application of a marine luminescent Vibrio sp. B4L for biosynthesis of silver nanoparticles with unique characteristics, biochemical properties, antibacterial and antibiofilm activities. Bioorg Chem. 2021;114:105102. doi:10.1016/j.bioorg.2021.105102
   PubMed Web of Science ®Google Scholar
• Prasath S, Palaniappan K. Is using nanosilver mattresses/pillows safe? A review of potential health implications of silver nanoparticles on human health. Environ Geochem Health. 2019;41(5):2295–2313. doi:10.1007/s10653-019-00240-7
   PubMed Web of Science ®Google Scholar
• Siddique MH, Aslam B, Imran M, et al. Effect of silver nanoparticles on biofilm formation and EPS production of multidrug-resistant Klebsiella pneumoniae. Biomed Res Int. 2020;2020:6398165. doi:10.1155/2020/6398165
   PubMed Web of Science ®Google Scholar